There have been 50 recent insider transactions recorded for Syndax Pharmaceuticals, Inc. (SNDX), including 35 buys and 12 sells. Total insider buying was valued at $2.87M and total insider selling at $1.76M.
Notable insiders with recent activity include Goldan Keith A., Metzger Michael A, Podlesak Dennis. Insider transactions can provide insights into how company leadership views the stock's valuation and future prospects.
Insider Transactions — SNDX
| Date |
Name |
Role |
Transaction |
Shares |
Avg. Price |
Value |
Shares Owned |
| 2026-02-09 |
Goldan Keith A. |
Chief Financial Officer |
Informative Sell |
3,410 |
$21.03 |
$71.71K |
140,429 |
| 2026-02-09 |
Metzger Michael A |
Chief Executive Officer |
Informative Sell |
17,159 |
$21.03 |
$360.82K |
491,690 |
| 2026-02-06 |
Goldan Keith A. |
Chief Financial Officer |
Informative Sell |
2,082 |
$20.62 |
$42.93K |
143,839 |
| 2026-02-06 |
Metzger Michael A |
Chief Executive Officer |
Informative Sell |
7,412 |
$20.62 |
$152.84K |
508,849 |
| 2026-02-04 |
Podlesak Dennis |
Director |
RSU Award |
48,000 |
- |
- |
239,763 |
| 2026-02-04 |
Katkin Keith |
Director |
RSU Award |
24,000 |
- |
- |
124,000 |
| 2026-02-04 |
Legault Pierre |
Director |
RSU Award |
24,000 |
- |
- |
114,000 |
| 2026-02-04 |
Goldan Keith A. |
Chief Financial Officer |
RSU Award |
21,500 |
- |
- |
115,171 |
| 2026-02-04 |
Metzger Michael A |
Chief Executive Officer |
RSU Award |
73,000 |
- |
- |
371,661 |
| 2026-02-04 |
Huber Martin H. Jr. |
Director |
RSU Award |
24,000 |
- |
- |
103,000 |
| 2026-02-04 |
Jarrett Jennifer |
Director |
RSU Award |
24,000 |
- |
- |
114,000 |
| 2026-02-04 |
Rizo Aleksandra |
Director |
RSU Award |
24,000 |
- |
- |
49,000 |
| 2026-02-04 |
Botwood Nicholas A.j. |
Head of R&d, CMO |
RSU Award |
24,000 |
- |
- |
59,165 |
| 2026-01-30 |
Goldan Keith A. |
Chief Financial Officer |
Other (Buy) |
1,219 |
$8.48 |
$10.34K |
93,671 |
| 2025-12-01 |
Goldan Keith A. |
Chief Financial Officer |
Gift (Given) |
1,224 |
- |
- |
92,452 |
| 2025-09-08 |
Metzger Michael A |
Chief Executive Officer |
Option Exercise |
157,307 |
$10.90 |
$1.71M |
- |
| 2025-08-18 |
Podlesak Dennis |
Director |
Option Exercise (Sell) |
19,200 |
$7.20 |
$138.24K |
- |
| 2025-08-15 |
Podlesak Dennis |
Director |
Informative Sell |
19,200 |
$15.54 |
$298.41K |
191,763 |
| 2025-08-14 |
Podlesak Dennis |
Director |
Informative Sell |
19,200 |
$14.19 |
$272.52K |
191,763 |
| 2025-07-31 |
Goldan Keith A. |
Chief Financial Officer |
Other (Buy) |
1,226 |
$8.43 |
$10.34K |
93,676 |
| 2025-07-16 |
Goldan Keith A. |
Chief Financial Officer |
Informative Sell |
1,296 |
$9.29 |
$12.03K |
92,450 |
| 2025-07-16 |
Metzger Michael A |
Chief Executive Officer |
Informative Sell |
7,534 |
$9.29 |
$69.95K |
298,661 |
| 2025-05-19 |
Katkin Keith |
Director |
Informative Buy |
10,000 |
$9.11 |
$91.12K |
100,000 |
| 2025-05-19 |
Goldan Keith A. |
Chief Financial Officer |
Informative Buy |
3,000 |
- |
- |
93,746 |
| 2025-05-19 |
Huber Martin H. Jr. |
Director |
Informative Buy |
5,000 |
$8.99 |
$44.95K |
79,000 |
| 2025-05-16 |
Botwood Nicholas A.j. |
Head of R&d, CMO |
Informative Buy |
11,765 |
$9.00 |
$105.83K |
35,165 |
| 2025-05-12 |
Botwood Nicholas A.j. |
Head of R&d, CMO |
Unknown |
215,000 |
$13.82 |
$2.97M |
- |
| 2025-03-14 |
Metzger Michael A |
Chief Executive Officer |
Option Exercise |
6,074 |
$7.20 |
$43.73K |
- |
| 2025-03-04 |
Metzger Michael A |
Chief Executive Officer |
Option Exercise |
7,814 |
$7.20 |
$56.26K |
- |
| 2025-02-10 |
Goldan Keith A. |
Chief Financial Officer |
Informative Sell |
3,777 |
$15.50 |
$58.56K |
90,746 |
| 2025-02-10 |
Metzger Michael A |
Chief Executive Officer |
Informative Sell |
13,288 |
$15.50 |
$206.02K |
300,121 |
| 2025-02-10 |
Gallagher Neil |
President, Head of R&d |
Informative Sell |
4,618 |
$15.50 |
$71.6K |
85,095 |
| 2025-02-05 |
Podlesak Dennis |
Director |
RSU Award |
50,000 |
- |
- |
191,763 |
| 2025-02-05 |
Katkin Keith |
Director |
RSU Award |
25,000 |
- |
- |
90,000 |
| 2025-02-05 |
Legault Pierre |
Director |
RSU Award |
25,000 |
- |
- |
90,000 |
| 2025-02-05 |
Goldan Keith A. |
Chief Financial Officer |
RSU Award |
18,500 |
- |
- |
71,123 |
| 2025-02-05 |
Metzger Michael A |
Chief Executive Officer |
RSU Award |
60,500 |
- |
- |
224,409 |
| 2025-02-05 |
Meury William |
Director |
RSU Award |
25,000 |
- |
- |
90,000 |
| 2025-02-05 |
Huber Martin H. Jr. |
Director |
RSU Award |
25,000 |
- |
- |
74,000 |
| 2025-02-05 |
Jarrett Jennifer |
Director |
RSU Award |
25,000 |
- |
- |
90,000 |
| 2025-02-05 |
Rizo Aleksandra |
Director |
RSU Award |
25,000 |
- |
- |
25,000 |
| 2025-02-05 |
Gallagher Neil |
President, Head of R&d |
RSU Award |
18,500 |
- |
- |
66,313 |
| 2024-06-14 |
Goldan Keith A. |
Chief Financial Officer |
Informative Buy |
1,250 |
$20.03 |
$25.04K |
52,623 |
| 2024-05-15 |
Rizo Aleksandra |
Officer |
Unknown |
- |
- |
- |
- |
| 2024-05-15 |
Rizo Aleksandra |
Director |
RSU Award |
35,000 |
$21.94 |
$767.9K |
35,000 |
| 2024-02-07 |
Podlesak Dennis |
Director |
RSU Award |
34,000 |
- |
- |
141,763 |
| 2024-02-07 |
Katkin Keith |
Director |
RSU Award |
17,000 |
- |
- |
65,000 |
| 2024-02-07 |
Legault Pierre |
Director |
RSU Award |
17,000 |
- |
- |
65,000 |
| 2024-02-07 |
Goldan Keith A. |
Chief Financial Officer |
RSU Award |
35,000 |
- |
- |
39,673 |
| 2024-02-07 |
Metzger Michael A |
Chief Executive Officer |
RSU Award |
107,250 |
- |
- |
124,909 |
■ Informative Buy/Sell — open market transaction (most significant)
■ Uninformative Buy — award, option exercise, conversion
■ Uninformative Sell — tax withholding, award vest sale
■ Neutral — gift, trust, expiry
